Importance of orexigenic counter-regulation for multiple targeted feeding inhibition

Obesity Research

Volumn 12, Issue 4, 2004, Pages 627-632

  Schusdziarra, Volker ^a,c   Zimmermann, Jens P ^a   Schick, Rafael R ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b BUNDESWEHRKRANKENHAUS ULM   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Central feeding regulation; Endogenous opioids; Glucagon like peptide 1; Neuropeptide Y; Xenin

Indexed keywords

FORMICIDAE;

ANOREXIGENIC AGENT; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; NALOXONE; NARCOTIC ANTAGONIST; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; OPIATE RECEPTOR; PEPTIDE; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; XENIN 25;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; EATING; HOMEOSTASIS; MALE; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; APPETITE DEPRESSANTS; EATING; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NEUROPEPTIDE Y; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, OPIOID;

EID: 3042847469     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2004.72     Document Type: Article

References (33)

1. World Health Organization. Obesity - Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva, Switzerland: World Health Organization; 2000.
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Health CW Jr. Body mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097-104.
3. Sjöström L, Rissanen A, Andersen T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998;352:167-72.
4. James WPT, Astrup A, Finer N, et al. for the STORM Study Group. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet. 2000;356:2119-25.
5. Gura T. Obesity drug pipeline not so fat. Science. 2003;299:849-52.
6. Bray GA, Tartaglia LA. Medicinal strategies in the treatment of obesity. Nature. 2000;404:672-7.
7. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:581-8.
8. Graham DJ, Green L. Further cases of valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:635.
9. Kalra S, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Rev. 1999;20:68-100.
10. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661-71.
11. Scrocchi LA, Brown TJ, MacLusky N, et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide receptor gene. Nat Med. 1996;2:1254-8.
12. Baggio L, Adatia F, Bock T, Brubaker PL, Drucker DJ. Sustained expression of exendin-4 does not perturb glucose homeostasis, β-cell mass, or food intake in metallothionein preproexendin transgenic mice. J Biol Chem. 2000;275:34471-7.
13. Scrocchi LA, Hill ME, Saleh J, Perkins B, Drucker DJ. Elimination of glucagon-like peptide 1R signalling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes. 2000;49:1552-60.
14. Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996;379:69-72.
15. Tang-Christensen M, Larsen PJ, Göke R, et al. Central administration of GLP-1 (7-36) amide inhibits food and water intake in rats. Am J Physiol. 1996;271:R848-56.
16. Gutzwiller JP, Göke B, Drewe J, et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut. 1999;44:81-6.
17. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998;101:515-20.
18. Alexiou C, Zimmermann JP, Schick RR, Schusdziarra V. Xenin-a novel suppressor of food intake in rats. Brain Res. 1998;800:294-9.
19. Levine AS, Morley JE. Neuropeptide Y: a potent inducer of consummatory behaviour in rats. Peptides. 1984;5:1025-9.
20. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behaviour in rats. Endocrinology. 1984;115:427-9.
21. Stanley BG, Leibowitz SF. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 1984;35:2635-42.
22. Grandison L, Guidotti A. Stimulation of food intake by muscimol and beta-endorphin. Neuropharmacology. 1977;16:533-5.
23. Jackson HC, Sewall RDE. Are delta opioid receptors involved in the regulation of food and water intake? Neuropharmacology. 1985;24:885-8.
24. Stanley BG, Lanthier D, Leibowitz SF. Multiple brain sites sensitive to feeding stimulation by opioid agonists: a cannula-mapping study. Pharmacol Biochem Behav. 1989;31:825-32.
25. Morley JE, Levine AS. Dynorphin (1-13) induces spontaneous feeding in rats. Life Sci. 1983;29:1901-3.
26. Giraudo SQ, Grace MK, Welch CC, Billington CJ, Levine AS. Naloxone's anorectic effect is dependent upon the relative palatability of food. Pharmacol Biochem Behav. 1993;46:917-21.
27. Marks-Kaufman R, Kanarek RB. Modifications in nutrient selection induced by naloxone in the rat. Psychopharmacology. 1981;74:321-4.
28. Glass MJ, Grace MK, Cleary JP, Billington CJ, Levine AS. Naloxone's effect on meal microstructure of sucrose and cornstarch diets. Am J Physiol. 2001;281:R1605-12.
29. 32]Neuropeptide Y: a competitive antagonist of NPY in rat hypothalamus. J Med Chem. 1994;37:811-5.
30. Hollopeter G, Erickson JC, Seeley RJ, Marsh DJ, Palmiter RD. Response of neuropeptide Y-deficient mice to feeding effectors. Regul Pept, 1998;75-76:383-9.
31. Schick RR, Schusdziarra V, Nussbaumer C, Classen M. Neuropeptide Y and food intake in fasted rats: effect of naloxone and site of action. Brain Res. 1991;552:232-9.
32. Tritos NA, Vicent D, Gillette J, Ludwig DS, Flier EE, Maratos-Flier E. Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus. Diabetes. 1998;47:1687-92.
33. Ludwig DS, Mountjoy KG, Tatro JB, et al. Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus of the rat. Am J Physiol. 1998;274:E627-33.